An expanded listing for Merck Serono's ERBITUX from today, to include the first line treatment of metastatic colorectal cancer.
![](https://e76bb9fd1f54a7a912eb-40f6ec802f763655ee14c32dfe77820e.ssl.cf4.rackcdn.com/aa02b937fe16a632cedd760a03fc81fa.jpg)
Latest Video
New Stories
-
New Omico podcast aims to help people navigate precision oncology and genomic innovation
February 11, 2025 - - Latest News -
Proponents of meaningful reform might consider pharmacy prescribing as a case study
February 11, 2025 - - Latest News -
PSA welcomes women’s health initiatives as significant step forward in improving access
February 10, 2025 - - Latest News -
'Unfortunately, there remain significant gaps in knowledge among healthcare professionals when it comes to menopause'
February 10, 2025 - - Latest News -
Sigma upgrades guidance as it prepares for Chemist Warehouse merger
February 10, 2025 - - Latest News -
Historical change on pharmacy prescribing could be a sign of more to come
February 10, 2025 - - Latest News -
Victorian official appointed to HTA Review implementation advisory group
February 10, 2025 - - Latest News